Non-Current Liabilities
Total Liabilities
Moderna Total Liabilities increased by 10.6% to $4.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.7%, from $2.64B to $4.08B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -5.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
A rising trend relative to assets may indicate increasing financial leverage and risk, while a declining trend suggests deleveraging.
Detailed definition
This is the aggregate of all current and non-current financial obligations owed by the company to outside parties. It se...
Peer comparison
Standardized across all industries; compared against total assets to determine solvency.
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.45B | $10.8B | $10.52B | $10.53B | $8.06B | $8.06B | $6.74B | $5.26B | $4.94B | $6B | $4.57B | $3.91B | $3.97B | $3.88B | $3.24B | $2.64B | $2.61B | $2.81B | $3.69B | $4.08B |
| QoQ Change | — | +14.3% | -2.5% | +0.1% | -23.5% | +0.1% | -16.5% | -21.9% | -6.2% | +21.5% | -23.7% | -14.4% | +1.4% | -2.3% | -16.4% | -18.6% | -1.0% | +7.4% | +31.5% | +10.6% |
| YoY Change | — | — | — | — | -14.7% | -25.3% | -36.0% | -50.0% | -38.8% | -25.7% | -32.1% | -25.7% | -19.6% | -35.3% | -29.1% | -32.6% | -34.2% | -27.6% | +13.8% | +54.7% |
Range$2.61B – $10.8B
CAGR-16.2%
Avg YoY Growth-22.4%
Median YoY Growth-28.4%
Current Streak3 quarters growth
Total Liabilities at Other Companies
Frequently Asked Questions
- What is Moderna's total liabilities?
- Moderna (MRNA) reported total liabilities of $4.08B in Q1 2026.
- How has Moderna's total liabilities changed year-over-year?
- Moderna's total liabilities increased by 54.7% year-over-year, from $2.64B to $4.08B.
- What is the long-term trend for Moderna's total liabilities?
- Over 5 years (2020 to 2025), Moderna's total liabilities has grown at a -5.0% compound annual growth rate (CAGR), from $4.78B to $3.69B.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and suppliers.